Fresenius reported EUR9.96B in Operating Expenses for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Akzo Nobel AKZA:NA EUR 2.5B 191M
Alcon AG ALC:SW USD 2.15B 215M
AstraZeneca AZN:LN USD 10.11B 376M
BASF BAS:GR EUR 19.21B 1.45B
Bayer BAYN:GR EUR 10.57B 486M
Davita Healthcare Partners DVA:US USD 2.66B 23.73M
E.ON EOAN:GR EUR 36.9B 10.02B
Fresenius FRE:GR EUR 9.96B 384M
Fresenius Medical Care FME:GR EUR 4.65B 20.48M
Fresenius Medical Care FMS:US EUR 4.65B 20.48M
Getinge GETIB:SS SEK 7.67B 1.84B
Givaudan GIVN:VX CHF 2.98B 37M
GlaxoSmithKline GSK:LN GBP 5.51B 1.13B
GN Store Nord GN:DC DKK 4.83B 495M
Hikma Pharmaceutical HIK:LN USD 1.24B 280M
Merck MRK:GR EUR 4.77B 199M
Novartis NOVN:VX USD 11.05B 378M
Philips PHIA:NA EUR 5.25B 588M
Roche Holding ROG:VX 25.06B 4.31B
Smith & Nephew PLC SN/:LN 2.36B 174M
William Demant Holding WDH:DC DKK 8.59B 680M